Literature DB >> 20421640

Identifying the cells breaching self-tolerance in autoimmunity.

Robert A Benson1, Agapitos Patakas, Paola Conigliaro, Catherine M Rush, Paul Garside, Iain B McInnes, James M Brewer.   

Abstract

Activation of auto-reactive T cells by activated dendritic cells (DCs) presenting self-Ag is widely assumed to be the precipitating event in the development of autoimmune disease. However, despite such widely held preconceptions, supporting data are scarce and subjective, particularly in experimental arthropathy. We have adapted a novel murine model of breach of self-tolerance allowing evaluation of the contribution of endogenous DCs to the development of autoimmune responses and disease. For the first time, we reveal the critical role played by conventional DCs, and the timing and location of this process. We further demonstrate the importance of this finding by clinically relevant, therapeutic manipulation of conventional DC function, resulting in decreased autoimmune phenotype and disease severity.

Entities:  

Mesh:

Year:  2010        PMID: 20421640     DOI: 10.4049/jimmunol.0903951

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Does deleting dendritic cells delete autoimmunity?

Authors:  Andrew M Platt; Gwendalyn J Randolph
Journal:  Immunity       Date:  2010-12-14       Impact factor: 31.745

Review 2.  The function of myeloid dendritic cells in rheumatoid arthritis.

Authors:  Mary Beth Yu; William H R Langridge
Journal:  Rheumatol Int       Date:  2017-02-24       Impact factor: 2.631

3.  TCRβ Sequencing Reveals Spatial and Temporal Evolution of Clonal CD4 T Cell Responses in a Breach of Tolerance Model of Inflammatory Arthritis.

Authors:  Shaima Al Khabouri; Robert A Benson; Catriona T Prendergast; Joshua I Gray; Thomas D Otto; James M Brewer; Paul Garside
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

4.  Th17 effector cells support B cell responses outside of germinal centres.

Authors:  Agapitos Patakas; Robert A Benson; David R Withers; Paola Conigliaro; Iain B McInnes; James M Brewer; Paul Garside
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

5.  Antigen depot is not required for alum adjuvanticity.

Authors:  Sharon Hutchison; Robert A Benson; Vivienne B Gibson; Abigail H Pollock; Paul Garside; James M Brewer
Journal:  FASEB J       Date:  2011-11-21       Impact factor: 5.191

Review 6.  Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases.

Authors:  Yuya Takakubo; Yrjö T Konttinen
Journal:  Clin Dev Immunol       Date:  2011-10-27

Review 7.  The thymus and rheumatology: should we care?

Authors:  Emilie Cosway; Graham Anderson; Paul Garside; Catriona Prendergast
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

8.  Divergent Immunomodulation Capacity of Individual Myelin Peptides-Components of Liposomal Therapeutic against Multiple Sclerosis.

Authors:  Vilena V Ivanova; Svetlana F Khaiboullina; Marina O Gomzikova; Ekaterina V Martynova; André M Ferreira; Ekaterina E Garanina; Damir I Sakhapov; Yakov A Lomakin; Timur I Khaibullin; Evgenii V Granatov; Farit A Khabirov; Albert A Rizvanov; Alexander Gabibov; Alexey Belogurov
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

Review 9.  Self-antigen presentation by dendritic cells in autoimmunity.

Authors:  Ann-Katrin Hopp; Anne Rupp; Veronika Lukacs-Kornek
Journal:  Front Immunol       Date:  2014-02-13       Impact factor: 7.561

10.  Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.

Authors:  Faye A H Cooles; Amy E Anderson; Andrew Skelton; Arthur G Pratt; Mariola S Kurowska-Stolarska; Iain McInnes; Catharien M U Hilkens; John D Isaacs
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.